|
Faculty |
|
|
Presenter & Moderator
Stewart J. Tepper, MD, FAHS
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire |
|
|
|
|
|
Presenter
Lawrence C. Newman, MD
NYU Langone Health
Preston Robert Tisch Center for Men’s Health
New York, New York |
|
|
|
|
|
|
Location |
Hyatt Regency Atlanta
Centennial II Ballroom
265 Peachtree Street, NW
Atlanta, GA 30303 |
|
|
Agenda |
5:45 AM:
Registration and Breakfast
6:15 AM:
Welcome and Introduction
6:25 AM:
Episodic and Chronic Migraine: Shared Pathways and Therapeutic Targets
6:45 AM:
Taking Stock of the Potential Impact of Anti-CGRP Monoclonal Antibodies on Migraine Prevention
7:05 AM:
Practicum: Identifying the Potential Nuances to Using Anti-CGRP Monoclonal Antibodies in Clinical Practice
7:20 AM:
Q&A and Conclusions
7:30 AM:
Adjourn |
|
Target Audience
This activity has been designed to meet the educational needs of neurologists and other healthcare professionals involved in the care of patients with migraines.
Providership, Credit, and Support
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) of through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Learning Institute, Inc. designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Providership
This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.
Support
This activity is supported by educational funding provided by Alder BioPharmaceuticals, Amgen, and Teva Pharmaceuticals.
This program isn't affiliated with American Neurological Association or its 2018 Annual Meeting. |
|
|